Retinal Investigation Using Optos OCT Device

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorOptos, PLC

About this trial

Retinal investigation using OCT with control and diseased eyes

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Male or female participants 18 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed.

Participants who understand the study and patient information sheet and can follow the instructions.

Participants who agree to participate in the study.

Control group where no retinal abnormalities were detected as part of the standard basic ophthalmic examination.

Disqualifiers

Inability to understand written and verbal English sufficiently to comprehend the study and provide informed consent

Ophthalmic disease other than condition under investigation.

Participants unable to tolerate ophthalmic imaging.

Cataract (unless deemed mild in the opinion of the investigator)

Trial design

Design model

Single group

Treatments tested in this trial

  • retinal functional imaging

    Device

    this is a proof of concept study

Treatment groups

120 Participants
are divided into 1 treatment group
Group A: standard imaging processOther 1 intervention

Trial outcomes

Primary outcomes

1

OCT physical response data

Response data per participant will be collected and analyzed

Time frame
6 months from recruitment start

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: